FIRST LIEN CREDIT AGREEMENT
FIRST LIEN CREDIT AGREEMENT, dated as of March 16, 2017, by and among BCPE EAGLE INTERMEDIATE HOLDINGS LLC, a Delaware limited liability company (“Holdings”), BCPE EAGLE BUYER LLC, a Delaware limited liability company (the “Borrower”), the lending institutions from time to time parties hereto as lenders (each, a “Lender” and, collectively, together with the Swingline Lender, the “Lenders”), and BARCLAYS BANK PLC, as the Administrative Agent, the Collateral Agent, a Letter of Credit Issuer, the Swingline Lender and a Lender (such terms and each other capitalized term used but not defined in this preamble or the recitals below having the meaning provided in Section 1.1).
WHEREAS, in connection with that certain Stock Purchase Agreement, dated as of December 16, 2016 (such Stock Purchase Agreement, as amended, restated, amended and restated, supplemented, waived, or otherwise modified from time to time, the “Eagle Acquisition Agreement”), by and among Borrower, Epic/Freedom, LLC, a Delaware limited liability company (“Eagle Seller”), Epic Acquisition, Inc., a Delaware corporation, and FHH Holdings, Inc., a Delaware corporation (together with Epic Acquisition, Inc., “Eagle”), Borrower will acquire, directly or indirectly, Eagle from Eagle Seller;
WHEREAS, in connection with that certain Agreement and Plan of Merger, dated as of December 23, 2016 (such Agreement and Plan of Merger, as amended, restated, amended and restated, supplemented, waived or otherwise modified from time to time, the “Iliad Merger Agreement”), by and among BCPE Eagle Holdings, Inc., a Delaware corporation, Borrower, BCPE Eagle Merger Sub Inc., a Delaware corporation (“Merger Sub”), PSA Healthcare Intermediate Holding Inc. (“Iliad”), a Delaware corporation, and PSA Healthcare Holding LLC, a Delaware limited liability company (“Iliad Seller”), Borrower will acquire, directly or indirectly, Iliad (the “Iliad Acquisition” and together with the Eagle Acquisition, the “Acquisitions”);
WHEREAS, pursuant and subject to the terms of the Iliad Merger Agreement, Merger Sub will merge with and into Iliad, with Iliad surviving as an indirect, Wholly-Owned Subsidiary of Borrower (the “Merger”);
WHEREAS, in connection with the foregoing, (i) the Borrower has requested that the Lenders extend credit in the form of (a) Initial Term Loans to the Borrower on the Closing Date, in an aggregate principal amount of $585,000,000 and (b) Revolving Credit Loans made available to the Borrower at any time and from time to time on and after the Closing Date and prior to the Revolving Credit Maturity Date in an aggregate principal amount at any time outstanding not in excess of $75,000,000 less the sum of (1) the aggregate Letters of Credit Outstanding at such time and (2) the aggregate principal amount of all Swingline Loans outstanding at such time, and (ii) the Borrower has requested the Swingline Lender to extend credit in the form of Swingline Loans at any time from time to time after the Closing Date and prior to the Swingline Maturity Date, in an aggregate principal amount at any time outstanding not in excess of $20,000,000, in accordance with the terms hereof;
WHEREAS, substantially concurrently with the effectiveness of this Agreement, the Borrower will establish a second lien term loan facility pursuant to the Second Lien Credit Documents (the “Second Lien Facility”) in an aggregate principal amount of $240,000,000;
WHEREAS, in connection with the foregoing, on or prior to the Closing Date, the Sponsors and co-investors arranged or designated by the Sponsors will make an equity investment (the “Sponsor Equity Investment”) in Borrower or a direct or indirect parent thereof (which equity investment, if other than common equity, will be on terms reasonably acceptable to the Joint Lead Arrangers and Bookrunners, and if such equity investment is made in a direct or indirect parent of Borrower, will be contributed to Borrower in an aggregate amount (when combined with any equity in Borrower or a direct or indirect parent thereof received by management of Eagle or Iliad and by other existing direct or indirect equityholders of Eagle or Iliad rolled over or re-invested in connection with the Acquisitions (the “Rollover Equity” and, such Rollover Equity together with the Sponsor Equity Investment, the “Equity Contribution”)) that is not less than 40% of the sum (the “Capitalization Amount”) of (i) the aggregate gross proceeds of the Loans and the Second Lien Loans to be borrowed on the Closing Date (excluding, in each case, the aggregate gross proceeds of any loans borrowed under the Revolving Credit Facility on the Closing Date for working capital purposes (including to fund any working capital payments or adjustments under the Acquisition Agreements)) or to replace, backstop or cash collateralize Existing Letters of Credit), plus (ii) the amount of such Equity Contribution.